Jastreboff, A.M., Aronne, L.J., Ahmad, N.N., et al
Its long-acting formula helps regulate hunger and improve blood sugar control, making it a strong option for managing obesity
[1] [2] The medication is administered as a once-weekly subcutaneous injection, typically on the same day each week to maintain consistent therapeutic levels in your bloodstream
The additional glucagon receptor activation is designed to increase energy expenditure, though head-to-head trials have not yet been conducted
In addition, although Mendelian randomization evidence generated using summary data from genome-wide association studies (GWAS) in this analysis shows that some effects of semaglutide treatment on the proteome may be mediated through body weight reduction and reduced T2D liability, analyses of the clinical trial data also support effects of semaglutide beyond those that can be explained by the observed weight loss and HbA 1c reductions